MedTrace Logo

Effect of Miralax NPO Time on Residual Gastric Volumes and Bowel Preparation

NCT07616908 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-06-01

No results posted yet for this study

Summary

The goal of this clinical trial is to assess differences in residual gastric volumes after stopping Miralax ingestion at different time points (1-4 hours) prior to anesthesia induction.

Conditions

  • Residual Gastric Contents
  • Polyethylene Glycol

Interventions

BEHAVIORAL

Stopping Miralax ingestion 4 hours prior to anesthesia induction

Stopping Miralax ingestion 4 hours prior to anesthesia induction

BEHAVIORAL

Stopping Miralax ingestion 3 hours prior to anesthesia induction

Stopping Miralax ingestion 3 hours prior to anesthesia induction

BEHAVIORAL

Stopping Miralax ingestion 2 hours prior to anesthesia induction

Stopping Miralax ingestion 2 hours prior to anesthesia induction

BEHAVIORAL

Stopping Miralax ingestion 1 hour prior to anesthesia induction

Stopping Miralax ingestion 1 hour prior to anesthesia induction

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-07-31
Primary Completion
2028-06-30
Completion
2028-06-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07616908 on ClinicalTrials.gov